Healthcare Equipment and Supplies
Company Overview of BioSET, Inc.
BioSET, Inc. is engaged in the medical research and development of synthetic bioactive peptides. It offers Amplex, an implantable combination device that is used in spine fusion surgery; products that are used for sports medicine applications; and peptide signaling molecules and various scaffold biomaterials for use in musculoskeletal applications. Its products are used in orthobiologics, spinal fusion, and other orthopedic applications. The company was founded in 2001 and is based in Rockville, Maryland. As of February 18, 2015, BioSET, Inc. operates as a subsidiary of Ferring Pharmaceuticals Inc.
9430 Key West Avenue
Rockville, MD 20850
Founded in 2001
Key Executives for BioSET, Inc.
Similar Private Companies By Industry
|.decimal, Inc.||United States|
|20/20 GeneSystems, Inc.||United States|
|20/20 Imaging LLC||United States|
|21st Century Scientific, Inc.||United States|
|21X Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact BioSET, Inc., please visit www.biosetinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.